Top-News

Iovance Biotherapeutics Aktie News

Aktie
WKN:  A2DT49 ISIN:  US4622601007 US-Symbol:  IOVA Branche:  Biotechnologie Land:  USA
2,225 $
+0,025 $
+1,14%
1,9112 € 20:54:09 Uhr
Depot/Watchlist
Marktkapitalisierung *
709,73 Mio. €
Streubesitz
36,98%
KGV
-6,07
Index-Zuordnung
-

Iovance Biotherapeutics News

20.06.25 - PR Newswire
Faruqi & Faruqi Reminds Iovance Biotherapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025 - IOVA
Faruqi & Faruqi Reminds Iovance Biotherapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025 - IOVA PR Newswire
20.06.25 - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit - IOVA
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit - IOVA PR Newswire
19.06.25 - PR Newswire
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit PR Newswire
19.06.25 - PR Newswire
Contact The Gross Law Firm by July 14, 2025 Deadline to Join Class Action Against Iovance Biotherapeutics, Inc.(IOVA)
Contact The Gross Law Firm by July 14, 2025 Deadline to Join Class Action Against Iovance Biotherapeutics, Inc.(IOVA) PR Newswire
17.06.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA PR Newswire
16.06.25 - PR Newswire
IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV
IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV PR Newswire
16.06.25 - PR Newswire
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
16.06.25 - PR Newswire
Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) should contact The Gross Law Firm about pending Class Action - IOVA
Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) should contact The Gross Law Firm about pending Class Action - IOVA PR Newswire
15.06.25 - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics PR Newswire
13.06.25 - PR Newswire
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit PR Newswire
13.06.25 - PR Newswire
IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV
IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV PR Newswire
13.06.25 - PR Newswire
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
13.06.25 - PR Newswire
Iovance Biotherapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - IOVA
Iovance Biotherapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - IOVA PR Newswire
12.06.25 - PR Newswire
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
12.06.25 - PR Newswire
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry PR Newswire
12.06.25 - PR Newswire
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry PR Newswire
12.06.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA PR Newswire
12.06.25 - PR Newswire
Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
Shareholders that lost money on Iovance Biotherapeutics, Inc.(IOVA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire
10.06.25 - PR Newswire
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
10.06.25 - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +1,03%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »